SynthesisFrontiers in pharmacology2022
Efficacy and Safety of Initial 5 Years of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis.
Hao Liao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.